Hemophilia Disease Presentation: Healthcare, Symptoms, and Treatment

This presentation focuses on hemophilia, a genetic disorder affecting blood clotting. It begins by defining hemophilia and highlighting its impact on individuals. The presentation details the various signs and symptoms, including unexplained bleeding and bruising. It then discusses treatment options, such as replacement therapy, desmopressin therapy, and clot-preserving medications. The presentation also emphasizes the crucial role of nurses in managing the disease, including providing information, addressing risk factors, and monitoring treatment effectiveness. References to relevant research articles are included to support the information provided. This presentation aims to provide a comprehensive overview of hemophilia for healthcare professionals and students.

Hemophilia Disease

Hemophilia Disease
It is a rare disease where the blood of
consumers does not clot as it lacks enough
blood-clotting proteins.
It is a genetic disease that can damage the
organs and tissues of the individuals.
Consumers with hemophilia produce a lesser
amount of factor VIII and IX (Ferraris, Boral,
Cohen, Smyth, & White, 2015).
This presentation highlights the problem of
hemophilia.

Signs and Symptoms
There are various signs and symptoms of
hemophilia including:
 Unexplained and excessive bleeding from cuts
 Deep bruises
 Rare bleeding after vaccinations
 In children, mysterious irritability
 Spontaneous nosebleeds (Swystun, & James, 2017).

Treatment
There are various treatment methods that
can be used for addressing hemophilia
disease such as:
 Replacement therapy (Example- To stop bleeding
episodes)
 Replace the lost blood clotting aspect (Example- treat
hemophilia A includes Advate and Xyntha.)
 Apply Desmopressin therapy (Example- manage
hemophilia in patients)
 Clot-preserving medications (Example- plasma-
derived factor VIII treatments).

Compilation
It is important for the care providers to find
risk factors associated with hemophilia.
Health care providers may provide
intervention programs for handling risks that
lead to hemophilia.
After applying replacement therapy on
individuals suffering from hemophilia nurses
should compile and check the effect of
applied therapy (Hartmann, & Croteau,
2016).

Nursing’s care
Nurses play a crucial character in the
reduction of hemophilia disease (Angelini,
Konkle, & Sood, 2016).
It is important for the nurses to provide
complete information about the disease and
helps patients for addressing the disease.
Nursing care can help patients to effectively
solve the problem of hemophilia disease and
manage risk factors linked with hemophilia.

References
Ferraris, V. A., Boral, L. I., Cohen, A. J., Smyth, S. S., &
White, G. C. (2015). Consensus review of the treatment
of cardiovascular disease in people with hemophilia A and
B. Cardiology in review, 23(2), 53.
Swystun, L. L., & James, P. D. (2017). Genetic diagnosis in
hemophilia and von Willebrand disease. Blood
reviews, 31(1), 47-56.
Hartmann, J., & Croteau, S. E. (2016). 2017 Clinical trials
update: Innovations in hemophilia therapy. American
journal of hematology, 91(12), 1252-1260.
Angelini, D., Konkle, B. A., & Sood, S. L. (2016). Aging
among persons with hemophilia: contemporary concerns.
In Seminars in hematology, 53(1), 35-39.